secwatch.observer — SEC 8-K summary
======================================

Issuer:     Telomir Pharmaceuticals, Inc. (TELO)
CIK:        0001971532
Form:       8-K
Filed at:   2024-02-13T23:59:59+00:00
Accession:  0001493152-24-006094
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Telomir Pharmaceuticals completes IPO of 1M shares at $7.00, raising $7M gross
------------------------------------------------------------------------------

- Priced 1,000,000 shares at $7.00; gross proceeds $7M. Shares began trading on Nasdaq Feb 9 under TELO.
- Underwriters granted 45-day option to purchase up to 150,000 additional shares at IPO price.
- Representative's warrants issued to Kingswood for 50,000 shares at $7.00, exercisable after 6-month lock.
- Kingswood Investments acted as sole book-running manager; underwriting discount 7% of gross proceeds.
- Proceeds to fund development of Telomir-1, a pre-clinical small molecule for age reversal.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1971532/000149315224006094/0001493152-24-006094-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1971532/000149315224006094/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-006094

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer